Publication: Malaria in pregnancy in the Asia-Pacific region
Issued Date
2012-01-01
Resource Type
ISSN
14744457
14733099
14733099
Other identifier(s)
2-s2.0-84055192692
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Lancet Infectious Diseases. Vol.12, No.1 (2012), 75-88
Suggested Citation
Marcus J. Rijken, Rose McGready, Machteld E. Boel, Rini Poespoprodjo, Neeru Singh, Din Syafruddin, Stephen Rogerson, François Nosten Malaria in pregnancy in the Asia-Pacific region. The Lancet Infectious Diseases. Vol.12, No.1 (2012), 75-88. doi:10.1016/S1473-3099(11)70315-2 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/15117
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Malaria in pregnancy in the Asia-Pacific region
Other Contributor(s)
Abstract
Most pregnant women at risk of for infection with Plasmodium vivax live in the Asia-Pacific region. However, malaria in pregnancy is not recognised as a priority by many governments, policy makers, and donors in this region. Robust data for the true burden of malaria throughout pregnancy are scarce. Nevertheless, when women have little immunity, each infection is potentially fatal to the mother, fetus, or both. WHO recommendations for the control of malaria in pregnancy are largely based on the situation in Africa, but strategies in the Asia-Pacific region are complicated by heterogeneous transmission settings, coexistence of multidrug-resistant Plasmodium falciparum and Plasmodium vivax parasites, and different vectors. Most knowledge of the epidemiology, effect, treatment, and prevention of malaria in pregnancy in the Asia-Pacific region comes from India, Papua New Guinea, and Thailand. Improved estimates of the morbidity and mortality of malaria in pregnancy are urgently needed. When malaria in pregnancy cannot be prevented, accurate diagnosis and prompt treatment are needed to avert dangerous symptomatic disease and to reduce effects on fetuses. © 2012 Elsevier Ltd.